Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My question is have you bought more since 2019?
Even with the Delta variant, the ability of COVID-19 vaccines to prevent hospitalization hasn't significantly dropped, CDC scientist says
https://www.yahoo.com/news/even-delta-variant-ability-covid-045427328.html
We need good antivirals now. Go B
Thanks, I copied Brilacidin starting at that current time discussing anti-bacterial, anti-inflammatory and discovered anti-viral properties.
Seems your link missed some characters. This one worked for me.
Great video from George Mason University on the in vitro Brilacidin studies. Start at 33 mins for details on the importance of anti-inflammatory drugs. Brilacidin details a bit past 40.
youtube.com/watch?v=kdFeqlm...
It took just eight weeks for the 208 patient ABSSSI trial. I give this by second week of September. These goal posts are getting heavy.
There's talk of a possible 4th wave coming.
https://time.com/6090218/fourth-wave-surpassed-third-in-some-states/
Or maybe it's here already.
Negotiations are very stealthful no one tips their hat. My opinion is with a successful clinical trial there will be offers. Hopefully a very big fish this time.
1000 SI Not according to Cell Research which compared the following-
Remdesivir SI 129.87
Cloroquine SI 88.5
Favipiravir SI 6.46
Penciclovir SI 4.17
Ribavirin SI 3.65
https://www.nature.com/articles/s41422-020-0282-0
We now know Brilacidin 426 SI
Thanks to those who had posted this earlier.
So Upton Sinclair was right "It is difficult to get a man to understand something, when his salary depends upon his not understanding it." GO Brilacidin.
“We look forward to sharing Brilacidin topline data in treating COVID-19 as soon as we have it in hand.”
With that tidbit you should be buying instead of posting:)
The old "somebody knows something" is a broken record.
If I thought Leo couldn't do it I would sell and moved on. In other words when I stop posting here I'm gone. Looking for great data anyone else.
Stock price does not dictate future results. Seen this many times. Data lock coming.
Yes. The irony being the beginning and the End.
So much concern and sleepless nights for some.. Go Leo
Fakers put up fake reports and fake walls. Go Leo
Yep B has yet to suffer failure. So far so good.
You don't know and neither does anyone outside of investigating the trial. FDA is cranky in that way. Share holders are hopeful.
Yep they threw out a couple bones to the big guys while we go to Russia. B's viral discovery was all done here. Just unreal.
Study shows B's unique ability in stopping pathogens quickly make it less likely of drug resistance developing.
"Modeled after Host Defense Proteins (HDPs), the “front-line” of defense in the body's innate immune system, it is a synthetic, non-peptidic small molecule that kills pathogens swiftly, significantly reducing the likelihood of drug resistance developing. Just as importantly, Brilacidin functions in a robust immunomodulatory capacity, lessening inflammation and promoting healing."
Successful trial could make for a huge discovery.imo
These variants have science and governments scrambling. Sadly I see this only getting worse in regards to vaccines. Hoping B is successful and can help turn it around.
FDA shoots down Ivermectin for covid-19.
https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Data lock pr would be viewed as a company milestone. The company is the business of progressing results not "get the shorts."
There is nothing to cover at this price imo. We had a small run to 60cents who wouldn't have covered by now. What am I missing, I thought you shorted a stock after a good run (like what happened here in 2015) not one that's been in the tank for a few years.
Leo says lets take a look at what we've been able to accomplished with B so far shall we.
No opinion on that but I do have a opinion of B stopping covid straight out of the IV bag. Killer B trial could be news real soon. Everyone is standing by. We need a covid-19 success.
There is no frigate like a hit piece to steal your money away.
What matters is what you think. The stock will climb on it's own merit.
Especially for the one operating the trap door. Look out below.
the call to sell at $2 in 2015 was a good one.
That was jaw dropping. Ok break over.
Yahoo reported it is that ok?
Because they received the spiked protein orally?
It's bubbled up to yahoo now. Confined space is never good imo.
https://www.yahoo.com/news/those-anti-covid-plastic-barriers-121635945.html
Three weeks since the last patient check. Multinational so you have that.
That prospect galls the heck out of some. Go B
I believe ctix just picked up old polymedix plans and ran with them without a deep dive into the current market competition. All hindsight now. Hopefully it finally pays off now.
Proving out the anti-bacterial properties in humans could help put us in the catbird seat when applying for EUA.
The ABSSSI trial gave us definitive proof that B is safe and effective as an IV treatment. Hopefully this translates to our covid-19 trial.
I hope 2.50 happens for you. With a successful covid P2 I plan on taking some cash and hanging around for licensing or buy out.
$2.50! That's where I sell and move on
How many phase3 trials had SAVA been in. Btw congrats on your sava play. Home runs are rarely hit.